These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1450846)

  • 1. Botulinum toxin in the treatment of chronic urinary retention in women.
    Fowler CJ; Betts CD; Christmas TJ; Swash M; Fowler CG
    Br J Urol; 1992 Oct; 70(4):387-9. PubMed ID: 1450846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).
    Panicker JN; Seth JH; Khan S; Gonzales G; Haslam C; Kessler TM; Fowler CJ
    BJU Int; 2016 May; 117(5):809-13. PubMed ID: 26435296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin.
    Gallien P; Robineau S; Verin M; Le Bot MP; Nicolas B; Brissot R
    Arch Phys Med Rehabil; 1998 Jun; 79(6):715-7. PubMed ID: 9630155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The etiology of urinary retention after surgery for genuine stress incontinence.
    FitzGerald MP; Brubaker L
    Neurourol Urodyn; 2001; 20(1):13-21. PubMed ID: 11135378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy.
    Kuo HC
    Urol Int; 2005; 75(3):247-51. PubMed ID: 16215314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximum urethral closure pressure and sphincter volume in women with urinary retention.
    Wiseman OJ; Swinn MJ; Brady CM; Fowler CJ
    J Urol; 2002 Mar; 167(3):1348-51; discussion 1351-2. PubMed ID: 11832729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urethral sphincter volumes in women with obstructed voiding and abnormal sphincter electromyographic activity.
    Noble JG; Dixon PJ; Rickards D; Fowler CJ
    Br J Urol; 1995 Dec; 76(6):741-6. PubMed ID: 8535718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the appearance of the urethral pressure profile trace correlate with the sphincter EMG findings in women with voiding dysfunction?
    Sihra N; Malde S; Panicker J; Kightley R; Solomon E; Hamid R; Ockrim J; Greenwell TJ; Pakzad M
    Neurourol Urodyn; 2018 Feb; 37(2):751-757. PubMed ID: 28678412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation.
    Smith CP; O'Leary M; Erickson J; Somogyi GT; Chancellor MB
    Int Urogynecol J Pelvic Floor Dysfunct; 2002; 13(3):185-6. PubMed ID: 12140713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urologic applications of botulinum toxin therapy for voiding dysfunction.
    Rackley R; Abdelmalak J
    Curr Urol Rep; 2004 Oct; 5(5):381-8. PubMed ID: 15461917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
    Kuo HC
    J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cause and natural history of isolated urinary retention in young women.
    Swinn MJ; Wiseman OJ; Lowe E; Fowler CJ
    J Urol; 2002 Jan; 167(1):151-6. PubMed ID: 11743295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation.
    Smith CP; O'Leary M; Erickson J; Somogyi GT; Chancellor MB
    Int Urogynecol J Pelvic Floor Dysfunct; 2002; 13(1):55-6. PubMed ID: 11999210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction.
    Phelan MW; Franks M; Somogyi GT; Yokoyama T; Fraser MO; Lavelle JP; Yoshimura N; Chancellor MB
    J Urol; 2001 Apr; 165(4):1107-10. PubMed ID: 11257648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentric needle electrodes are superior to perineal surface-patch electrodes for electromyographic documentation of urethral sphincter relaxation during voiding.
    Mahajan ST; Fitzgerald MP; Kenton K; Shott S; Brubaker L
    BJU Int; 2006 Jan; 97(1):117-20. PubMed ID: 16336340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity.
    Jiang YH; Jhang JF; Chen SF; Kuo HC
    Low Urin Tract Symptoms; 2019 Jan; 11(1):66-71. PubMed ID: 29024564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromyographic abnormalities in the urethral and anal sphincters of women with idiopathic retention of urine.
    Webb RJ; Fawcett PR; Neal DE
    Br J Urol; 1992 Jul; 70(1):22-5. PubMed ID: 1638369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unusual history and the urological applications of botulinum neurotoxin.
    Hanchanale VS; Rao AR; Martin FL; Matanhelia SS
    Urol Int; 2010; 85(2):125-30. PubMed ID: 20664247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal electromyographic activity (decelerating burst and complex repetitive discharges) in the striated muscle of the urethral sphincter in 5 women with persisting urinary retention.
    Fowler CJ; Kirby RS
    Br J Urol; 1985 Feb; 57(1):67-70. PubMed ID: 4038618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity.
    Kuo HC
    Urology; 2003 Mar; 61(3):550-4. PubMed ID: 12639645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.